Dion Stevenson

Dion Stevenson is an accomplished sales leader in the pharmaceutical and medical device industries, currently serving as the Rare Disease Regional Sales Director at Biogen since October 2017. Recognized with the 2022 President’s Club and the 2024 Top Performance Leadership Award, Stevenson oversees strategic direction and leadership for the Great Plains Region, managing a team of Rare Disease Account Executives to promote Spinraza®, the first FDA-approved therapy for spinal muscular atrophy. Previous roles at Biogen included Sr. Manager, Thought Leader Liaison and Rare Disease Account Executive, achieving multiple accolades for exceptional performance. Stevenson's career also includes significant experience at Grifols, Merit Medical Systems, Allergan, and GlaxoSmithKline, with expertise in engaging health professionals and driving sales execution across various therapeutic areas. Stevenson holds a Bachelor's of Science in Business Management from the University of Kansas and William Jewell College.